Insmed Incorporated (INSM) Earnings History
Annual and quarterly earnings data from 1999 to 2025
Loading earnings history...
INSM EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
INSM Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 79.4% | -194.0% | -210.5% |
| 2024 | 76.4% | -241.5% | -251.2% |
| 2023 | 78.5% | -232.5% | -245.6% |
| 2022 | 77.5% | -186.4% | -196.3% |
| 2021 | 76.6% | -199.0% | -230.6% |
Download Data
Export INSM earnings history in CSV or JSON format
Free sign-in required to download data
Insmed Incorporated (INSM) Earnings Overview
As of May 8, 2026, Insmed Incorporated (INSM) reported trailing twelve-month net income of -$1.28B, reflecting -15.1% year-over-year growth. The company earned $-5.98 per diluted share over the past four quarters, with a net profit margin of -210.5%.
Looking at the long-term picture, INSM's historical earnings data spans multiple years. The company achieved its highest annual net income of $118M in fiscal 2009.
Insmed Incorporated is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RARE (-$609M net income, -85.4% margin), ALNY ($577M net income, 8.4% margin), BMRN ($269M net income, 10.8% margin), INSM has room to improve margins relative to the peer group. Compare INSM vs RARE →
INSM Earnings vs Peers
Earnings metrics vs comparable public companies
INSM Historical Earnings Data (1999–2025)
27 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$1.28B | -39.7% | -$1.18B | $-6.41 | -210.5% | -194.0% |
| 2024 | -$914M | -21.9% | -$878M | $-5.57 | -251.2% | -241.5% |
| 2023 | -$750M | -55.7% | -$710M | $-5.34 | -245.6% | -232.5% |
| 2022 | -$482M | -10.8% | -$457M | $-3.91 | -196.3% | -186.4% |
| 2021 | -$435M | -47.8% | -$375M | $-3.88 | -230.6% | -199.0% |
| 2020 | -$294M | -15.6% | -$265M | $-3.01 | -178.9% | -161.3% |
| 2019 | -$254M | +21.6% | -$235M | $-3.01 | -186.4% | -172.4% |
| 2018 | -$324M | -68.3% | -$307M | $-4.22 | -3297.2% | -3124.9% |
| 2017 | -$193M | -9.3% | -$189M | $-2.89 | - | - |
| 2016 | -$176M | -49.2% | -$173M | $-2.85 | - | - |
Full INSM Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See INSM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs INSM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare INSM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonINSM — Frequently Asked Questions
Quick answers to the most common questions about buying INSM stock.
Is INSM growing earnings?
INSM EPS fell to $-5.98, with earnings declining -15.1%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-1.3B.
What are INSM's profit margins?
Insmed Incorporated net margin is -210.5%, with operating margin at -194.0%. Below-average margins reflect competitive or cost pressures.
How consistent are INSM's earnings?
INSM earnings data spans 1999-2025. The declining earnings trend is -15.1% YoY. Historical data enables comparison across business cycles.